TITLE

Acute Megaloblastic Anemia Induced by High-Dose Trimethoprim-Sulfamethoxazole

AUTHOR(S)
Kobrinsky, Nathan; Ramsay, Norma K.C.
PUB. DATE
June 1981
SOURCE
Annals of Internal Medicine;Jun81, Vol. 94 Issue 6, p780
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Presents a case study of the development of acute megaloblastic anemia in a 22-year-old woman after treatment with high-dose trimethoprim-sulfamethoxazole for pneumocystis pneumonia. Background on the therapeutic applications of trimethoprim-sulfamethoxazole; Medical history of the patient; Treatment administered to the patient.
ACCESSION #
7001332

 

Related Articles

  • Prophylaxis Recommendations for Pneumocystis. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;3/25/2002, Vol. 15 Issue 3, p110 

    Reports the indication of primary prophylaxis of Pneumocystis for patients with history of Pneumocystis carinii pneumonia. Efficacy of trimethoprim-sulfamethoxazole (TMP-SMX); Considerations in discontinuing primary and secondary prophylaxis; Dosage for TMP-SMX.

  • Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis carinii Pneumonia. Winston, Drew J.; Lau, William K.; Gale, Robert Peter; Young, Lowell S. // Annals of Internal Medicine;Jun80, Vol. 92 Issue 6, p762 

    Presents a study which evaluated trimethoprim-sulfamethoxazole for the treatment of patients with Pneumocystis carinii pneumonia. Background on the clinical data of patients involved in the study; Comparison of clinical responses and side effects associated with trimethoprim-sulfamethoxazole...

  • Questions Regarding the Effectiveness of Trimethoprim-Sulfamethoxazole (Cotrimoxazole) Prophylaxis in African Children. Gill, Christopher J.; Hamer, Davidson; Thea, Donald M. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p863 

    Presents a letter to the editor in the September 15, 2003 issue of 'Clinical Infectious Diseases,' regarding the article 'Ineffectiveness of trimethoprime-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii...

  • Reply. Madhi, Shabir A.; Klugman, Keith P. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p864 

    Responds to comments on the authors' article 'Ineffectiveness of trimethoprime-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia,' published in a 2003 issue of 'Clinical Infectious Diseases.'

  • Cotrimoxazole.  // Reactions Weekly;11/21/2009, Issue 1279, p16 

    The article describes the case of a 44-year-old man with Pneumocystis carinii pneumonia (PCP) who died despite treatment with cotrimoxazole. The patient, who had undergone renal transplant, received antilymphocyte globulin before he was given ciclosporin, prednisolone and mycophenolate mofetil...

  • Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Sattler, Fred R.; Cowan, Robert; Nielsen, Donald M.; Ruskin, Joel; Sattler, F R; Cowan, R; Nielsen, D M; Ruskin, J // Annals of Internal Medicine;8/15/88, Vol. 109 Issue 4, p280 

    Study Objective: To ascertain the efficacy and toxicity of trimethoprim-sulfamethoxazole or pentamidine when either is given alone during the entire treatment period for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome (AIDS).Design:...

  • Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome. Gordin, Fred M.; Simon, Gwynn L.; Wofsy, Constance B.; Mills, John // Annals of Internal Medicine;Apr84, Vol. 100 Issue 4, p495 

    Presents a study which examined the adverse reactions to trimethoprim-sulfamethoxazole of patients with AIDS who were treated for Pneumocystis carinii pneumonia. Definitions of drug toxicity used in the study; Information on a less toxic drug than trimethoprim-sulfamethoxazole for treatment of...

  • Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Wharton, J. Marcus; Coleman, Diana Lewis; Wofsy, Constance B.; Luce, John M.; Blumenfeld, Walter; Hadley, W. Keith; Ingram-Drake, Leslie; Volberding, Paul A.; Hopewell, Philip C.; Wharton, J M; Coleman, D L; Wofsy, C B; Luce, J M; Blumenfeld, W; Hadley, W K; Ingram-Drake, L; Volberding, P A; Hopewell, P C // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p37 

    Forty patients with the acquired immunodeficiency syndrome (AIDS) and their first episodes of Pneumocystis carinii pneumonia were assigned at random to receive either trimethoprim-sulfamethoxazole or pentamidine isethionate. The two groups did not differ significantly in the severity of...

  • Cotrimoxazole.  // Reactions Weekly;1/23/2010, Issue 1285, p13 

    The article describes the cases of two 24-year-old male patients who developed severe and prolonged cholestasis while receiving cotrimoxazole for treatment of Pneumocystis carinii pneumonia (PCP). The first patient developed respiratory failure and required ventilation after receiving...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics